Impaired glucose and insulin homeostasis in moderate-severe CKD

Ian H. De Boer, Leila Zelnick, Maryam Afkarian, Ernest Ayers, Laura Curtin, Jonathan Himmelfarb, T. Alp Ikizler, Steven E. Kahn, Bryan Kestenbaum, Kristina Utzschneider

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Kidney disease leads to clinically relevant disturbances in glucose and insulin homeostasis, but the pathophysiology in moderate-severe CKD remains incompletely defined. In a cross-sectional study of 59 participants with nondiabetic CKD (mean EGFR =37.6 ml/min per 1.73 m2) and 39 healthy control subjects, we quantified insulin sensitivity, clearance, and secretion and glucose tolerance using hyperinsulinemiceuglycemic clamp and intravenous and oral glucose tolerance tests. Participants with CKD had lower insulin sensitivity than participants without CKD (mean[SD] 3.9[2.0] versus 5.0 [2.0] mg/min per mU/ml; P,0.01). Insulin clearance correlated with insulin sensitivity (r=0.72; P,0.001) and was also lower in participants with CKD than controls (876 [226] versus 998 [212] ml/min; P,0.01). Adjustment for physical activity, diet, fat mass, and fatfree mass in addition to demographics and smoking partially attenuated associations ofCKDwith insulin sensitivity (adjusted difference,20.7; 95%confidence interval,21.4 to 0.0mg/min per mU/ml) and insulin clearance (adjusted difference, 285; 95% confidence interval, 2160 to 210 ml/min). Among participants with CKD, EGFR did not significantly correlate with insulin sensitivity or clearance. Insulin secretion and glucose tolerance did not differ significantly between groups, but 65%of participants with CKD had impaired glucose tolerance. In conclusion, moderate-severe CKD associated with reductions in insulin sensitivity and clearance that are explained, in part, by differences in lifestyle and body composition. We did not observe aCKD-specificdeficit in insulin secretion, but the combinationof insulin resistance and inadequate augmentation of insulin secretion led to a high prevalence of impaired glucose tolerance.

Original languageEnglish (US)
Pages (from-to)2861-2871
Number of pages11
JournalJournal of the American Society of Nephrology
Volume27
Issue number9
DOIs
StatePublished - Jan 1 2016
Externally publishedYes

Fingerprint

Insulin Resistance
Homeostasis
Insulin
Glucose
Glucose Intolerance
Glucose Tolerance Test
Confidence Intervals
Kidney Diseases
Body Composition
Life Style
Healthy Volunteers
Cross-Sectional Studies
Smoking
Fats
Demography
Exercise
Diet

ASJC Scopus subject areas

  • Nephrology

Cite this

De Boer, I. H., Zelnick, L., Afkarian, M., Ayers, E., Curtin, L., Himmelfarb, J., ... Utzschneider, K. (2016). Impaired glucose and insulin homeostasis in moderate-severe CKD. Journal of the American Society of Nephrology, 27(9), 2861-2871. https://doi.org/10.1681/ASN.2015070756

Impaired glucose and insulin homeostasis in moderate-severe CKD. / De Boer, Ian H.; Zelnick, Leila; Afkarian, Maryam; Ayers, Ernest; Curtin, Laura; Himmelfarb, Jonathan; Ikizler, T. Alp; Kahn, Steven E.; Kestenbaum, Bryan; Utzschneider, Kristina.

In: Journal of the American Society of Nephrology, Vol. 27, No. 9, 01.01.2016, p. 2861-2871.

Research output: Contribution to journalArticle

De Boer, IH, Zelnick, L, Afkarian, M, Ayers, E, Curtin, L, Himmelfarb, J, Ikizler, TA, Kahn, SE, Kestenbaum, B & Utzschneider, K 2016, 'Impaired glucose and insulin homeostasis in moderate-severe CKD', Journal of the American Society of Nephrology, vol. 27, no. 9, pp. 2861-2871. https://doi.org/10.1681/ASN.2015070756
De Boer, Ian H. ; Zelnick, Leila ; Afkarian, Maryam ; Ayers, Ernest ; Curtin, Laura ; Himmelfarb, Jonathan ; Ikizler, T. Alp ; Kahn, Steven E. ; Kestenbaum, Bryan ; Utzschneider, Kristina. / Impaired glucose and insulin homeostasis in moderate-severe CKD. In: Journal of the American Society of Nephrology. 2016 ; Vol. 27, No. 9. pp. 2861-2871.
@article{50d97d1e63954bdfa0592557143df96c,
title = "Impaired glucose and insulin homeostasis in moderate-severe CKD",
abstract = "Kidney disease leads to clinically relevant disturbances in glucose and insulin homeostasis, but the pathophysiology in moderate-severe CKD remains incompletely defined. In a cross-sectional study of 59 participants with nondiabetic CKD (mean EGFR =37.6 ml/min per 1.73 m2) and 39 healthy control subjects, we quantified insulin sensitivity, clearance, and secretion and glucose tolerance using hyperinsulinemiceuglycemic clamp and intravenous and oral glucose tolerance tests. Participants with CKD had lower insulin sensitivity than participants without CKD (mean[SD] 3.9[2.0] versus 5.0 [2.0] mg/min per mU/ml; P,0.01). Insulin clearance correlated with insulin sensitivity (r=0.72; P,0.001) and was also lower in participants with CKD than controls (876 [226] versus 998 [212] ml/min; P,0.01). Adjustment for physical activity, diet, fat mass, and fatfree mass in addition to demographics and smoking partially attenuated associations ofCKDwith insulin sensitivity (adjusted difference,20.7; 95{\%}confidence interval,21.4 to 0.0mg/min per mU/ml) and insulin clearance (adjusted difference, 285; 95{\%} confidence interval, 2160 to 210 ml/min). Among participants with CKD, EGFR did not significantly correlate with insulin sensitivity or clearance. Insulin secretion and glucose tolerance did not differ significantly between groups, but 65{\%}of participants with CKD had impaired glucose tolerance. In conclusion, moderate-severe CKD associated with reductions in insulin sensitivity and clearance that are explained, in part, by differences in lifestyle and body composition. We did not observe aCKD-specificdeficit in insulin secretion, but the combinationof insulin resistance and inadequate augmentation of insulin secretion led to a high prevalence of impaired glucose tolerance.",
author = "{De Boer}, {Ian H.} and Leila Zelnick and Maryam Afkarian and Ernest Ayers and Laura Curtin and Jonathan Himmelfarb and Ikizler, {T. Alp} and Kahn, {Steven E.} and Bryan Kestenbaum and Kristina Utzschneider",
year = "2016",
month = "1",
day = "1",
doi = "10.1681/ASN.2015070756",
language = "English (US)",
volume = "27",
pages = "2861--2871",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "9",

}

TY - JOUR

T1 - Impaired glucose and insulin homeostasis in moderate-severe CKD

AU - De Boer, Ian H.

AU - Zelnick, Leila

AU - Afkarian, Maryam

AU - Ayers, Ernest

AU - Curtin, Laura

AU - Himmelfarb, Jonathan

AU - Ikizler, T. Alp

AU - Kahn, Steven E.

AU - Kestenbaum, Bryan

AU - Utzschneider, Kristina

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Kidney disease leads to clinically relevant disturbances in glucose and insulin homeostasis, but the pathophysiology in moderate-severe CKD remains incompletely defined. In a cross-sectional study of 59 participants with nondiabetic CKD (mean EGFR =37.6 ml/min per 1.73 m2) and 39 healthy control subjects, we quantified insulin sensitivity, clearance, and secretion and glucose tolerance using hyperinsulinemiceuglycemic clamp and intravenous and oral glucose tolerance tests. Participants with CKD had lower insulin sensitivity than participants without CKD (mean[SD] 3.9[2.0] versus 5.0 [2.0] mg/min per mU/ml; P,0.01). Insulin clearance correlated with insulin sensitivity (r=0.72; P,0.001) and was also lower in participants with CKD than controls (876 [226] versus 998 [212] ml/min; P,0.01). Adjustment for physical activity, diet, fat mass, and fatfree mass in addition to demographics and smoking partially attenuated associations ofCKDwith insulin sensitivity (adjusted difference,20.7; 95%confidence interval,21.4 to 0.0mg/min per mU/ml) and insulin clearance (adjusted difference, 285; 95% confidence interval, 2160 to 210 ml/min). Among participants with CKD, EGFR did not significantly correlate with insulin sensitivity or clearance. Insulin secretion and glucose tolerance did not differ significantly between groups, but 65%of participants with CKD had impaired glucose tolerance. In conclusion, moderate-severe CKD associated with reductions in insulin sensitivity and clearance that are explained, in part, by differences in lifestyle and body composition. We did not observe aCKD-specificdeficit in insulin secretion, but the combinationof insulin resistance and inadequate augmentation of insulin secretion led to a high prevalence of impaired glucose tolerance.

AB - Kidney disease leads to clinically relevant disturbances in glucose and insulin homeostasis, but the pathophysiology in moderate-severe CKD remains incompletely defined. In a cross-sectional study of 59 participants with nondiabetic CKD (mean EGFR =37.6 ml/min per 1.73 m2) and 39 healthy control subjects, we quantified insulin sensitivity, clearance, and secretion and glucose tolerance using hyperinsulinemiceuglycemic clamp and intravenous and oral glucose tolerance tests. Participants with CKD had lower insulin sensitivity than participants without CKD (mean[SD] 3.9[2.0] versus 5.0 [2.0] mg/min per mU/ml; P,0.01). Insulin clearance correlated with insulin sensitivity (r=0.72; P,0.001) and was also lower in participants with CKD than controls (876 [226] versus 998 [212] ml/min; P,0.01). Adjustment for physical activity, diet, fat mass, and fatfree mass in addition to demographics and smoking partially attenuated associations ofCKDwith insulin sensitivity (adjusted difference,20.7; 95%confidence interval,21.4 to 0.0mg/min per mU/ml) and insulin clearance (adjusted difference, 285; 95% confidence interval, 2160 to 210 ml/min). Among participants with CKD, EGFR did not significantly correlate with insulin sensitivity or clearance. Insulin secretion and glucose tolerance did not differ significantly between groups, but 65%of participants with CKD had impaired glucose tolerance. In conclusion, moderate-severe CKD associated with reductions in insulin sensitivity and clearance that are explained, in part, by differences in lifestyle and body composition. We did not observe aCKD-specificdeficit in insulin secretion, but the combinationof insulin resistance and inadequate augmentation of insulin secretion led to a high prevalence of impaired glucose tolerance.

UR - http://www.scopus.com/inward/record.url?scp=84983562749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983562749&partnerID=8YFLogxK

U2 - 10.1681/ASN.2015070756

DO - 10.1681/ASN.2015070756

M3 - Article

VL - 27

SP - 2861

EP - 2871

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 9

ER -